Find a Tender
complete
Official procurement procedure
Provision of Testing Services and Sample Analysis
Laboratory services
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Public Health England: "Provision of Testing Services and Sample Analysis". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Public Health England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Public Health England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Public Health England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
3.3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 58 active published awards; 52 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityPublic Health England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published9 Feb 2021, 22:56 GMT | Last source update9 Feb 2021, 22:56 GMT | Recurring procurementNot published |
ClassificationLaboratory services | ||
Delivery area UK | ||
OCIDocds-h6vhtk-0291da | ||
What is being bought
PHE has been tasked by DHSC to urgently undertake a study to evaluate the immune response following COVID-19 vaccines as part of the National Immunisation Programme. This has been identified as a high national public health priority and a key aspect of this study requires taking 2000 samples for cellular work over a 24-month period. The UK Vaccines Taskforce have selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Aligning PHE's study with this decision will ensure that it is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies.
What changed
From the official release history
- Status changed to complete
9 Feb 2021, 22:56 GMT - Official notice release published
9 Feb 2021, 22:56 GMT - Buyer information updated
9 Feb 2021, 22:56 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedOxford Immunotec will provide testing services and sample analysis to assist PHE in its evaluation of immune responses following COVID-19 vaccines used in the National Immunisation Programme.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
9 Feb 2021, 22:56 GMT - Award active
Not published · Not published - Contract active
Signed 9 Feb 2021, 00:00 GMT · £240,000
Commercial outcome and competition
Awards Oxford Immunotec Ltd Not published · Not published · active |
Contracts Contract £240,000 · signed 9 Feb 2021, 00:00 GMT · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Public Health England
Contracting authority GB-FTS-2800Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe justification to source these services from Oxford Immunotec is to enable PHE to adhere with the decision made by the UK Vaccines Taskforce who selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Oxford Immunotec was chosen as a result of the competitive process for its expertise in T cell measurement and its unique ability to provide T-SPOT® technology, the only globally regulated ELISPOT platform - which is currently being used clinically for identifying T cells made in response to another respiratory pathogen responsible for Tuberculosis.
Aligning with this verdict will ensure that the National Immunisation Programme being carried out by PHE is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies. The Vaccines Taskforce has emphasised that it is important to be able to assess the different vaccines head-to-head and employing Oxford Immunotec's T-SPOT technology will measure the magnitude of the SARS-CoV-2 protein-specific T cell response of different vaccine candidates for cross-comparisons. |